Researchers, Patients Meet to Discuss Stevens-Johnson Syndrome
Vanderbilt University Medical CenterScientists and patients from all over the world are gathering in Vancouver, Canada, on Friday and Saturday to discuss new discoveries and future direction in the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), a drug-induced disease that has a mortality of up to 50%.